FKDSF (Fukuda Denshi Co) Cash Payments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FKDSF Fukuda Denshi Co Ltd FKDSF
83 GF Score
Price $42.55
GF Value $26.75
! 5 Warning Signs
View Full Analysis

What is Fukuda Denshi Co Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

FKDSF
83GF Score
Fukuda Denshi Co Ltd FKDSF
Cash Payments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fukuda Denshi Co (FKDSF) Overvalued in 2026?

Based on GuruFocus' analysis, Fukuda Denshi Co stock appears to be overvalued. The current stock price of $42.55 is trading 59.1% above its estimated GF Value™ of $26.75.

Key valuation signals for FKDSF:

  • Cash Payments:
  • GF Value™: $26.75 vs. price of $42.55 (59.1% above fair value)
  • GF Score™: 83/100 with 5 warning signs

No single metric tells the full story. See the FKDSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fukuda Denshi Co Business Description

Other Exchanges 6960:Japan
Address 39-4, Hongo 3-chome, Bunkyo-ku, Tokyo, JPN, 113-8483
Fukuda Denshi Co Ltd develops and manufactures medical electronic equipment. The firm operates in four segments: physiological diagnostic equipment, patient monitoring equipment, medical treatment equipment, and consumables and other products. The physiological diagnostic equipment business sells electrocardiographs, vascular screening systems, and blood cell counters. The patient monitoring equipment segment sells patient monitors and transmitters. The medical treatment equipment segment contributes the largest proportion of revenue and sells pacemakers and medical equipment for home treatment. The consumables and other products segment sells disposable electrodes and consumables used for the firm's devices. Fukuda Denshi generates the vast majority of its sales in Japan.
83GF Score

Get the complete analysis for FKDSF

Cash Payments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.55
Price
$26.75
GF Value